Study of Arimidex and Radiotherapy Sequencing

Summary

The purpose of this study is to compare TGF-β1 change in concomitant with that in sequential Arimidex in postmenopausal women with breast cancer, as measured by the proportion of patients with an elevation of TGF-β1 level at the 4th week after initiation of radiotherapy relative to the pre-treatment baseline.

Timeline

Start

2011-07

Primary completion

2014-12

Completion

2015-07

Drugs

Indications